رونق تولید
today : Wednesday, August 21, 2019

News > No research can yield a product with government money

Home Page > news 


Sattari on Opening Ceremony and Start of Work of Cell Health Biotech Accelerator:

No research can yield a product with government money

No research can yield a product with government money

Emphasizing the successful output and achievement of activity of accelerators in the fields of biotechnology, human and livestock drugs and vaccinations in the future, the vice president for science and technology affairs stated: after some time, these youth can form manufacturing knowledge-based companies with the investment of the private sector.

According to the public relations and information center of the Vice-Presidency for science and technology affairs, Sorena Sattari, the vice president for science and technology affairs, expressed in a meeting with journalists after attending the opening ceremony of cell health biotech accelerator accompanied by Azizollah Shahbazi, the governor of Alborz and managers of the province: the output and achievements of activity of accelerators in the fields of biotechnology, human and livestock drugs and vaccines will be outstanding in the future, and this knowledge-based company is an example of significant measures taken by the youth in this area. Without a doubt, these youth can establish manufacturing knowledge-based companies after a while and with the investment of the private sector.

In the next part of his speech, Sattari pointed out the visit of “Tamad” company, affirming: the company has been helping the country to get rid of dependencies by producing effective drug-based medicines and should continue to support it. Today, eight new products have been unveiled, mainly in the field of active pharmaceutical ingredients.

The president of the national elites foundation confirmed the serious support of the biotechnology field by the Vice-Presidency, asserting: we have aimed to decrease dependency on import of effective medication compounds by these measures. About $600 million worth of pharmaceuticals imports are made in the human sector alone, with 80-90% of projects being implemented in this field.

Sattari visited the knowledge-based company that produces raw material and asserted: the output and achievement of activity of accelerators in the fields of biotechnology, human and livestock drugs and vaccinations will be prominent in the future and this knowledge-based company is an example of significant measures taken by the youth in this area. Without a doubt, these youth can establish manufacturing knowledge-based companies after a while and with the investment of the private sector.

The vice president for science and technology affairs pointed out the visit of “Tamad Co.”, affirming: the raw materials of the company have helped the country to decrease dependency by producing effective drug substances and should continue to support it. Today, eight new products have been unveiled, mainly in the field of active pharmaceutical ingredients.

Hardware and Software Support

During the ceremony, Dr. Houman Kaghaznian, the CEO of cell health technology accelerator, stated: the primary core of this accelerator is Fan Yakhte Alborz knowledge-based company, which is active in the field of biotechnology materials and products. Software and hardware support is provided to companies and technologists active in the field of recombinant drugs in various platforms, including the production of treatments based on stem cells and the production of strains of various types of vaccines required by the health system of the country.

The unique feature of this biotech accelerator is that it also has a growth center, so the ideas that are successful in accelerating the process, up to the stage of documentation and production up to the required bovine batch and pedigree clinical studies, are guided based on GMP requirements






Personalization

Color

Font

A+ A-